NCT04504331 2026-02-12Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast CancerStanford UniversityPhase 1 Terminated4 enrolled 11 charts
NCT02708511 2018-04-05Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast CancerStanford UniversityPhase 1 Terminated2 enrolled